Form 8-K - Current report:
SEC Accession No. 0001384101-25-000083
Filing Date
2025-06-18
Accepted
2025-06-18 16:46:56
Documents
13
Period of Report
2025-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20250617.htm   iXBRL 8-K 58249
2 EX-10.1 ex1018-k06x17x2025.htm EX-10.1 196707
  Complete submission text file 0001384101-25-000083.txt   411162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20250617.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20250617_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20250617_pre.xml EX-101.PRE 13060
15 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20250617_htm.xml XML 2921
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 251057537
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)